Cara Therapeutics Inc CARA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 3:57 PM EST
19.81quote price arrow up+0.12 (+0.61%)
Volume
259,669
52 week range
8.88 - 22.60

...

Loading . . .

KEY STATS

  • Open19.92
  • Day High20.20
  • Day Low19.48
  • Prev Close19.69
  • 52 Week High22.60
  • 52 Week High Date02/11/21
  • 52 Week Low8.88
  • 52 Week Low Date03/18/20
  • Market Cap987.13M
  • Shares Out49.83M
  • 10 Day Average Volume0.71M
  • Dividend-
  • Dividend Yield-
  • Beta1.36
  • 1 Year % Change20.97

RATIOS/PROFITABILITY

  • EPS (TTM)-2.12
  • P/E (TTM)-9.35
  • Fwd P/E (NTM)-16.33
  • EBITDA (MRQ)-102.68M
  • ROE (MRQ)-58.34%
  • Revenue (MRQ)27.50M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-360.35%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date03/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Cara Therapeutics Inc News

There is no recent news for this security.

Latest CARA News From Our Partners

QUOTE FINDER

Profile

MORE
Cara Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing chemical entities designed to alleviate pain and pruritus by focusing on kappa opioid receptors. It is developing a class of product candidates that target the body's peripheral nervous system. The Company operates through the activities related to the discovery and development of therapeutics to treat serious medical conditions, including pain and...
Derek Chalmers Ph.D.
President
Thomas Reilly
Chief Financial Officer
Richard Makara
Vice President
Address
4 Stamford Plz
Stamford, CT
06902-3834
United States